Curis

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Curis ( CRIS) is a drug discovery and development company that is committed to leveraging signaling pathway drug technologies in seeking to develop next generation network-targeted cancer therapies. This stock is trading up 5.3% to $4.22 in recent trading.

Today's Range: $4.06-$4.23

52-Week Range: $2.87-$5.65

Volume: 211,000

Three-Month Average Volume: 411,944

From a technical perspective, CRIS is trending higher here with light volume as it finds some buying interest around some previous support levels near $4. This move is starting to push CRIS within range of triggering a near-term breakout trade. That trade will hit once CRIS manages to take out some near-term overhead resistance at $4.35 to $4.44, and then once it clears its 200-day at $4.67 with high volume.

Traders should now look for long-biased trades in CRIS once it manages to sustain a move or close above those levels with volume that's near or above 411,944 shares. If that breakout triggers soon, then CRIS will have a great chance of re-testing or possibly taking out its next major overhead resistance levels at $5.16 to $5.50.

To see more stocks under-$10 that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Winderemere, Fla.

RELATED LINKS:



Follow Stockpickr on Twitter and become a fan on Facebook.
At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on stocks, options, futures, commodities and currencies. He is also an outside contributor to Beconequity.com and maintains the website Maddmoney.net, which he sold to Blue Wave Advisors in 2008. Roberto studied International Business at The Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany.

If you liked this article you might like

These 5 Stocks Under $10 Could Make You a Lot of Money

Anavex Presents Meaningless Results in Alzheimer's Drug Study

4 Stocks Under $10 to Trade for Big Breakouts

Why Prana Biotechnology (PRAN) Stock Is Surging Today

3 Biotech Stocks Under $10 in Breakout Territory